Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “dual-target”

4 pharma patents match "dual-target" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "dual-target" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “dual-target” · 30,257 patents in full index Clear search

  1. US 12331058

    SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted

  2. US 12286405

    Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted

  3. US 12281164

    Genetically engineered dual-targeting chimeric antigen receptor and use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted

  4. US 12145974

    Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.